Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N O'Higgins

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Clinical Chemistry|October 1, 1992
Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survivalM J Duffy, D Reilly, J P Brouillet, et al.
Journal of Medical Screening|August 31, 2004
Surgical intervention in screen-detected patients versus symptomatic patients with breast cancerM F Dillon, A D K Hill, C M Quinn, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 2003
Objective measurement of breast cancer oestrogen receptor status through digital image analysisR Mofidi, R Walsh, P F Ridgway, et al.
Irish Journal of Medical Science|May 9, 2007
Changing patterns of thyroid carcinomaB Dijkstra, R S Prichard, A Lee, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 7, 2003
Lack of prognostic effect of Cox-2 expression in primary breast cancer on short-term follow-upL M Kelly, A D K Hill, S Kennedy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2008
ADAM-17 predicts adverse outcome in patients with breast cancerP M McGowan, E McKiernan, F Bolster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Predictive testing for BRCA1 and 2 mutations: a male contributionP A Daly, C Nolan, A Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancerA Di Leo, J Crown, J M Nogaret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 1998
Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3)M Gershanovich, H A Chaudri, D Campos, et al.
Oncology Reports|June 10, 2005
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaborationN Grebenchtchikov, T M Maguire, R Riisbro, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Clinical Chemistry|October 1, 1992
Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survivalM J Duffy, D Reilly, J P Brouillet, et al.
Journal of Medical Screening|August 31, 2004
Surgical intervention in screen-detected patients versus symptomatic patients with breast cancerM F Dillon, A D K Hill, C M Quinn, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 2003
Objective measurement of breast cancer oestrogen receptor status through digital image analysisR Mofidi, R Walsh, P F Ridgway, et al.
Irish Journal of Medical Science|May 9, 2007
Changing patterns of thyroid carcinomaB Dijkstra, R S Prichard, A Lee, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 7, 2003
Lack of prognostic effect of Cox-2 expression in primary breast cancer on short-term follow-upL M Kelly, A D K Hill, S Kennedy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2008
ADAM-17 predicts adverse outcome in patients with breast cancerP M McGowan, E McKiernan, F Bolster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Predictive testing for BRCA1 and 2 mutations: a male contributionP A Daly, C Nolan, A Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancerA Di Leo, J Crown, J M Nogaret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 1998
Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3)M Gershanovich, H A Chaudri, D Campos, et al.
Oncology Reports|June 10, 2005
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaborationN Grebenchtchikov, T M Maguire, R Riisbro, et al.
Pageof 9